PUBLISHER: KBV Research | PRODUCT CODE: 1429148
PUBLISHER: KBV Research | PRODUCT CODE: 1429148
Asia Pacific Nanotechnology Drug Delivery Market Size, Share & Trends Analysis Report By Formulation (Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others), By Application, By Country and Growth Forecast, 2023 - 2030
The Asia Pacific Nanotechnology Drug Delivery Market would witness market growth of 9.6% CAGR during the forecast period (2023-2030).
Personalized medicine, tailoring treatments to individual patient characteristics, has gained prominence recently. Nanotechnology facilitates the realization of personalized medicine by offering customizable drug delivery systems. The tunable properties of nanoparticles allow for the adjustment of factors such as size, surface charge, and drug release kinetics to match the specific requirements of each patient. This individualized approach holds great potential for optimizing treatment outcomes and minimizing adverse effects.
Nanotechnology has revolutionized cancer therapy by offering multifaceted solutions. Nanoparticles can be designed to passively target tumor tissues through the enhanced permeability and retention (EPR) effect, exploiting the leaky vasculature characteristic of tumors. Moreover, the blood-brain barrier (BBB) poses a significant challenge in treating neurological disorders, limiting the entry of therapeutic agents into the brain. Nanotechnology offers innovative solutions to overcome this barrier and deliver drugs to the central nervous system. Nanoparticles can be engineered to traverse the BBB through various mechanisms, including receptor-mediated transcytosis and encapsulation in carriers designed to exploit endogenous transport mechanisms.
Cancer incidence in India has increased significantly in recent years, with environmental factors, lifestyle modifications, and an aging population all playing a role. China has been experiencing an increase in neurological cases, including conditions such as Alzheimer's disease, Parkinson's disease, and various neurological disorders. The rising prevalence of these conditions has created a demand for innovative and targeted drug delivery solutions, and nanotechnology has emerged as a promising avenue for addressing the challenges associated with neurological treatments. As per the data released in 2022 by the Shanghai Municipal People's Government, there are about 10 million people with Alzheimer's disease in China. With the rising aging population, the figure is expected to surpass 30 million in 2050. Thus, the growing number of cancer and Alzheimer's disease cases in Asia Pacific will help in the growth of the regional market.
The China market dominated the Asia Pacific Nanotechnology Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $9,244 Million by 2030. The Japan market is registering a CAGR of 8.9% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.3% during (2023 - 2030).
Based on Formulation, the market is segmented into Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others. Based on Application, the market is segmented into Oncology & Hematology, Infectious Diseases, Orthopedics, Neurology, Immunology, Urology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- AbbVie, Inc.
- Pfizer Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen, Inc.
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
Asia Pacific Nanotechnology Drug Delivery Market Report Segmentation
By Formulation
- Polymer-Based Nanomedicine
- Lipid-Based Nanomedicine
- Nanocrystals
- Others
By Application
- Oncology & Hematology
- Infectious Diseases
- Orthopedics
- Neurology
- Immunology
- Urology
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Nanotechnology Drug Delivery Market, by Formulation
- 1.4.2 Asia Pacific Nanotechnology Drug Delivery Market, by Application
- 1.4.3 Asia Pacific Nanotechnology Drug Delivery Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Asia Pacific Nanotechnology Drug Delivery Market, by Formulation
- 4.1 Asia Pacific Polymer-Based Nanomedicine Market, by Country
- 4.2 Asia Pacific Lipid-Based Nanomedicine Market, by Country
- 4.3 Asia Pacific Nanocrystals Market, by Country
- 4.4 Asia Pacific Others Market, by Country
Chapter 5. Asia Pacific Nanotechnology Drug Delivery Market, by Application
- 5.1 Asia Pacific Oncology & Hematology Market, by Country
- 5.2 Asia Pacific Infectious Diseases Market, by Country
- 5.3 Asia Pacific Orthopedics Market, by Country
- 5.4 Asia Pacific Neurology Market, by Country
- 5.5 Asia Pacific Immunology Market, by Country
- 5.6 Asia Pacific Urology Market, by Country
- 5.7 Asia Pacific Others Market, by Country
Chapter 6. Asia Pacific Nanotechnology Drug Delivery Market, by Country
- 6.1 China Nanotechnology Drug Delivery Market
- 6.1.1 China Nanotechnology Drug Delivery Market, by Formulation
- 6.1.2 China Nanotechnology Drug Delivery Market, by Application
- 6.2 Japan Nanotechnology Drug Delivery Market
- 6.2.1 Japan Nanotechnology Drug Delivery Market, by Formulation
- 6.2.2 Japan Nanotechnology Drug Delivery Market, by Application
- 6.3 India Nanotechnology Drug Delivery Market
- 6.3.1 India Nanotechnology Drug Delivery Market, by Formulation
- 6.3.2 India Nanotechnology Drug Delivery Market, by Application
- 6.4 South Korea Nanotechnology Drug Delivery Market
- 6.4.1 South Korea Nanotechnology Drug Delivery Market, by Formulation
- 6.4.2 South Korea Nanotechnology Drug Delivery Market, by Application
- 6.5 Singapore Nanotechnology Drug Delivery Market
- 6.5.1 Singapore Nanotechnology Drug Delivery Market, by Formulation
- 6.5.2 Singapore Nanotechnology Drug Delivery Market, by Application
- 6.6 Malaysia Nanotechnology Drug Delivery Market
- 6.6.1 Malaysia Nanotechnology Drug Delivery Market, by Formulation
- 6.6.2 Malaysia Nanotechnology Drug Delivery Market, by Application
- 6.7 Rest of Asia Pacific Nanotechnology Drug Delivery Market
- 6.7.1 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Formulation
- 6.7.2 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Application
Chapter 7. Company Profiles
- 7.1 AbbVie, Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Acquisition and Mergers:
- 7.1.6 SWOT Analysis
- 7.2 Pfizer, Inc.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional & Segmental Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Partnerships, Collaborations, and Agreements:
- 7.2.6 SWOT Analysis
- 7.3 Johnson & Johnson
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental &Regional Analysis
- 7.3.4 SWOT Analysis
- 7.4 Novartis AG
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 SWOT Analysis
- 7.5 Bristol-Myers Squibb Company
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Partnerships, Collaborations, and Agreements:
- 7.5.6 SWOT Analysis
- 7.6 AstraZeneca PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
- 7.7 Amgen, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.7.5 SWOT Analysis
- 7.8 Merck KGaA
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Acquisition and Mergers:
- 7.8.6 SWOT Analysis
- 7.9 Teva Pharmaceutical Industries Ltd.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.9.5 SWOT Analysis
- 7.10. Sanofi S.A.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense
- 7.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 2 Asia Pacific Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 3 Asia Pacific Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 4 Asia Pacific Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 5 Asia Pacific Polymer-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
- TABLE 6 Asia Pacific Polymer-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
- TABLE 7 Asia Pacific Lipid-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
- TABLE 8 Asia Pacific Lipid-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
- TABLE 9 Asia Pacific Nanocrystals Market, by Country, 2019 - 2022, USD Million
- TABLE 10 Asia Pacific Nanocrystals Market, by Country, 2023 - 2030, USD Million
- TABLE 11 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
- TABLE 12 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
- TABLE 13 Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 14 Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 15 Asia Pacific Oncology & Hematology Market, by Country, 2019 - 2022, USD Million
- TABLE 16 Asia Pacific Oncology & Hematology Market, by Country, 2023 - 2030, USD Million
- TABLE 17 Asia Pacific Infectious Diseases Market, by Country, 2019 - 2022, USD Million
- TABLE 18 Asia Pacific Infectious Diseases Market, by Country, 2023 - 2030, USD Million
- TABLE 19 Asia Pacific Orthopedics Market, by Country, 2019 - 2022, USD Million
- TABLE 20 Asia Pacific Orthopedics Market, by Country, 2023 - 2030, USD Million
- TABLE 21 Asia Pacific Neurology Market, by Country, 2019 - 2022, USD Million
- TABLE 22 Asia Pacific Neurology Market, by Country, 2023 - 2030, USD Million
- TABLE 23 Asia Pacific Immunology Market, by Country, 2019 - 2022, USD Million
- TABLE 24 Asia Pacific Immunology Market, by Country, 2023 - 2030, USD Million
- TABLE 25 Asia Pacific Urology Market, by Country, 2019 - 2022, USD Million
- TABLE 26 Asia Pacific Urology Market, by Country, 2023 - 2030, USD Million
- TABLE 27 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
- TABLE 28 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
- TABLE 29 Asia Pacific Nanotechnology Drug Delivery Market, by Country, 2019 - 2022, USD Million
- TABLE 30 Asia Pacific Nanotechnology Drug Delivery Market, by Country, 2023 - 2030, USD Million
- TABLE 31 China Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 32 China Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 33 China Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 34 China Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 35 China Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 36 China Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 37 Japan Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 38 Japan Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 39 Japan Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 40 Japan Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 41 Japan Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 42 Japan Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 43 India Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 44 India Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 45 India Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 46 India Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 47 India Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 48 India Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 49 South Korea Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 50 South Korea Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 51 South Korea Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 52 South Korea Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 53 South Korea Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 54 South Korea Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 55 Singapore Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 56 Singapore Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 57 Singapore Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 58 Singapore Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 59 Singapore Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 60 Singapore Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 61 Malaysia Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 62 Malaysia Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 63 Malaysia Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 64 Malaysia Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 65 Malaysia Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 66 Malaysia Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 67 Rest of Asia Pacific Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
- TABLE 68 Rest of Asia Pacific Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
- TABLE 69 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
- TABLE 70 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
- TABLE 71 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
- TABLE 72 Rest of Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
- TABLE 73 Key information - AbbVie, Inc.
- TABLE 74 Key Information - Pfizer, Inc.
- TABLE 75 Key Information - Johnson & Johnson
- TABLE 76 Key Information - Novartis AG
- TABLE 77 Key Information - Bristol-Myers Squibb Company
- TABLE 78 KEY INFORMATION - AstraZeneca PLC
- TABLE 79 Key Information - Amgen, Inc.
- TABLE 80 key Information - Merck KGaA
- TABLE 81 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 82 Key Information - Sanofi S.A.
